World Health Organization (WHO) partners Unitaid have announced an agreement with the Pfizer laboratories to manufacture generic oral drugs to be used against COVID-19.
The Pfizer laboratories Friday announced the development of an experimental pill to treat COVID-19, which the pharmaceutical company claims cuts down the risk of hospitalization and death by 89% of people infected with the virus.